What peptides do—and do not—tell you
You may have heard names like GLP-1, GHK-Cu, BPC-157, and TB-500. Knowing a peptide's name does not tell you what it does or whether it is right for you. The conversation should start with the science, your goals, and guidance from a licensed healthcare provider.
Areas of peptide research
Metabolic wellness: Tirzepatide activates GIP and GLP-1 receptors and is FDA-approved for specific indications. For appropriate patients, it may support appetite regulation, blood sugar management, and weight management.
Skin and aesthetic wellness: Some peptides are being studied in connection with skin biology, cellular signaling, and tissue processes. Results vary and research is still evolving.
Recovery and physical wellness: Certain emerging peptides are being investigated in laboratory and preclinical research. Much of the research is preliminary, so they should not be marketed as treatments for injuries, pain, inflammation, or specific medical conditions.
Cellular and longevity research: Researchers are studying signaling pathways involved in aging and cellular function. A peptide being studied for a longevity-related pathway does not mean it has been proven to extend lifespan or reverse aging.
So, which peptide is right for you?
That is not a question answered by a blog post. The right approach depends on the therapy, your goals, medical history, medications, risk factors, and the evidence available for that use. Our goal is to help you understand your options—not sell you on a trend.
Your biology is individual. Your wellness plan should be, too.
Some peptide therapies and compounded medications are not FDA-approved. Research and regulatory status vary significantly by compound and intended use. Peptide treatments require evaluation and approval by a licensed healthcare provider. This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent disease.
